Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial: a rebuttal

Research output: Contribution to journalLetterpeer-review

3 Citations (Scopus)
Original languageEnglish
Article numberN/A
Pages (from-to)500 - 502
Number of pages3
JournalJOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume10
Issue number3
DOIs
Publication statusPublished - Mar 2012

Cite this